Key result
Intraoperative NSAID administration was not associated with an increased risk of postoperative acute kidney injury compared to no NSAIDs (4.2% vs. 4.2%, p > 0.999).
Why the study?
Does intraoperative NSAID administration increase the incidence of acute kidney injury in patients undergoing major noncardiac surgery?
Cohort (n=11,139)
No
Does intraoperative NSAID administration increase the incidence of acute kidney injury in patients undergoing major noncardiac surgery?
Absolute Event Rate: 4.2% vs 4.2%
p-value: p=> 0.999
Intraoperative NSAID use during major noncardiac surgery does not appear to increase the risk of postoperative acute kidney injury.
Should not yet change practice avoiding intraoperative NSAIDs for AKI risk; leaves open confirmation by randomized trials.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used as part of multimodal analgesia, but their association with acute kidney injury (AKI) in patients undergoing elective surgery remains uncertain. We conducted a retrospective, propensity score-matched study at a single-center academic hospital (ChiCTR2300076725). The primary outcome was the incidence of AKI, defined by the Kidney Disease: Improving Global Outcomes (KDIGO) serum creatinine criteria, compared between patients who did and did not receive NSAIDs during surgery. Secondary outcomes included AKI severity staging and prolonged postoperative hospitalization (≥7 days). A total of 11,139 patients were included, with 3,361 in the NSAIDs group and 7,778 in the control group. After propensity score matching (PSM), 3,361 matched pairs were obtained. The incidence of postoperative AKI was comparable between the NSAIDs and control groups after matching (4.2% vs. 4.2%, p > 0.999). The distribution of AKI stages (p = 0.830) and the median duration of postoperative hospital stay were also comparable between the two groups (both 6 days, p = 0.290). Sequentially adjusted logistic regression models consistently showed no significant association between NSAIDs and AKI, AKI staging, or prolonged hospitalization, both before and after PSM. Stratified analyses by NSAID type and dose-response analyses revealed no significant association with AKI. A sensitivity analysis using complete cases without imputation (n = 9,385) yielded consistent results. In conclusion, intraoperative NSAIDs administration was not independently associated with an increased risk of postoperative AKI in patients undergoing major noncardiac surgery.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Major noncardiac surgery (n=11,139). Intraoperative nonsteroidal anti-inflammatory drugs (NSAIDs) vs. No intraoperative NSAIDs was evaluated on Incidence of acute kidney injury (AKI) defined by KDIGO criteria (p=> 0.999). Intraoperative NSAID administration was not associated with an increased risk of postoperative acute kidney injury compared to no NSAIDs (4.2% vs. 4.2%, p > 0.999).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: